Use of Bayesian Modeling for Risk Assessment and Robustness Evaluation

Article Properties
  • Language
    English
  • Publication Date
    2024/01/29
  • Indian UGC (journal)
  • Refrences
    20
  • Adam J. Freitag Chemical Process Development, Bristol Myers Squibb, One Squibb Drive, New Brunswick, New Jersey 08903, United States ORCID
  • Amanda J. Rogers Chemical Process Development, Bristol Myers Squibb, One Squibb Drive, New Brunswick, New Jersey 08903, United States
  • Jose E. Tabora Chemical Process Development, Bristol Myers Squibb, One Squibb Drive, New Brunswick, New Jersey 08903, United States
  • Daniel S. Treitler Chemical Process Development, Bristol Myers Squibb, One Squibb Drive, New Brunswick, New Jersey 08903, United States ORCID
Cite
Freitag, Adam J., et al. “Use of Bayesian Modeling for Risk Assessment and Robustness Evaluation”. Organic Process Research &Amp; Development, vol. 28, no. 2, 2024, pp. 511-23, https://doi.org/10.1021/acs.oprd.3c00325.
Freitag, A. J., Rogers, A. J., Tabora, J. E., & Treitler, D. S. (2024). Use of Bayesian Modeling for Risk Assessment and Robustness Evaluation. Organic Process Research &Amp; Development, 28(2), 511-523. https://doi.org/10.1021/acs.oprd.3c00325
Freitag, Adam J., Amanda J. Rogers, Jose E. Tabora, and Daniel S. Treitler. “Use of Bayesian Modeling for Risk Assessment and Robustness Evaluation”. Organic Process Research &Amp; Development 28, no. 2 (2024): 511-23. https://doi.org/10.1021/acs.oprd.3c00325.
Freitag AJ, Rogers AJ, Tabora JE, Treitler DS. Use of Bayesian Modeling for Risk Assessment and Robustness Evaluation. Organic Process Research & Development. 2024;28(2):511-23.
Refrences
Title Journal Journal Categories Citations Publication Date
Development of a Commercial Process for Deucravacitinib, a Deuterated API for TYK2 Inhibition Organic Process Research & Development
  • Science: Chemistry
  • Science: Chemistry: Organic chemistry
  • Technology: Chemical technology: Polymers and polymer manufacture
  • Science: Chemistry
13 2022
The ICH Q8 Definition of Design Space: A Comparison of the Overlapping Means and the Bayesian Predictive Approaches Statistics in Biopharmaceutical Research
  • Medicine: Medicine (General): Computer applications to medicine. Medical informatics
  • Science: Biology (General)
  • Science: Mathematics: Probabilities. Mathematical statistics
  • Science: Mathematics
30 2010
Bayesian probabilistic modeling in pharmaceutical process development AIChE Journal
  • Technology: Chemical technology: Chemical engineering
  • Technology: Chemical technology: Chemical engineering
  • Science: Chemistry
12 2019
Development and Implementation of a Quality Control Strategy for an Atropisomer Impurity Grounded in a Risk-Based Probabilistic Design Space Organic Process Research & Development
  • Science: Chemistry
  • Science: Chemistry: Organic chemistry
  • Technology: Chemical technology: Polymers and polymer manufacture
  • Science: Chemistry
4 2019
Finding Design Space and a Reliable Operating Region Using a Multivariate Bayesian Approach with Experimental Design Quality Technology & Quantitative Management 25 2009